Bio-Techne To Buy Cliniqa

(RTTNews) - Bio-Techne Corp. (TECH) said Friday that it has agreed to buy Cliniqa Corp., which specializes in the manufacturing and commercialization of quality controls and calibrators as well as bulk reagents used in the clinical diagnostic market.

Cliniqa's controls and reagents are used in a wide variety of diagnostic tests for such pathologies as cardiac disease, diabetes, cancer, immunological disorders, therapeutic drug monitoring, urine analysis and toxicology. Cliniqa has a solid track record of profitable and cash generative growth.

Cliniqa, based in San Marcos, California, has about 75 employees.

Cliniqa Chief Executive Officer Kevin Gould and other members of the Cliniqa leadership team will remain in place following the closing.

The deal is expected to close on or around July 1.